Vasc Health Risk Manag. 2007;3(1):23-30.

Moexipril and left ventricular hypertrophy.

Source

University of Oklahoma, Oklahoma City, USA. gsc5@yahoo.com

Abstract

Angiotensin-converting enzyme (ACE) inhibitors today are the standard therapy of patients with myocardial infarction and heart failure due to their proven beneficial effects in left ventricular remodeling and left ventricular function. ACE inhibitors have also been demonstrated to lead to regression of left ventricular hypertrophy (LVH). It is believed that the mechanism of action of LVH regression with ACE inhibitors arises from more than simple blood pressure reduction. LVH is an important risk factor for cardiovascular disease morbidity and mortality independent of blood pressure. Moexipril hydrochloride is a long-acting, non-sulfhydryl ACE inhibitor that can be taken once daily for the treatment of hypertension. Moexipril has now also been demonstrated to have beneficial effects on LVH and can lead to LVH regression.

PMID:: 17583172; [PubMed - indexed for MEDLINE]
PMCID:: PMC1994034

Free PMC Article

Images from this publication.See all images (2) Free text

Publication Types, MeSH Terms, Substances

Publication Types

Review

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Supplemental Content

Save items

Related citations in PubMed

Regression of left ventricular hypertrophy with moexipril, an angiotensin-converting enzyme inhibitor, in hypertensive patients. [Am J Ther. 2005]
Regression of left ventricular hypertrophy with moexipril, an angiotensin-converting enzyme inhibitor, in hypertensive patients.
Sayegh F, Topouchian J, Hlawaty M, Olzewska M, Asmar R. Am J Ther. 2005 Jan-Feb; 12(1):3-8.
A study of the relationships between angiotensin- converting enzyme gene, chymase gene polymorphisms, pharmacological treatment with ACE inhibitor and regression of left ventricular hypertrophy in essential hypertension patients treated with benazepril. [Ann Hum Biol. 2005]
A study of the relationships between angiotensin- converting enzyme gene, chymase gene polymorphisms, pharmacological treatment with ACE inhibitor and regression of left ventricular hypertrophy in essential hypertension patients treated with benazepril.
He H, Li LM, Cao WH, Sun NL, Liu MZ, Hu YH. Ann Hum Biol. 2005 Jan-Feb; 32(1):30-43.
Comparison of the effects of angiotensin receptor antagonist, angiotensin converting enzyme inhibitor, and their combination on regression of left ventricular hypertrophy of diabetes type 2 patients on recent onset hemodialysis therapy. [Ther Apher Dial. 2004]
Comparison of the effects of angiotensin receptor antagonist, angiotensin converting enzyme inhibitor, and their combination on regression of left ventricular hypertrophy of diabetes type 2 patients on recent onset hemodialysis therapy.
Suzuki H, Kanno Y, Kaneko K, Kaneko M, Kotaki S, Mimura T, Takane H. Ther Apher Dial. 2004 Aug; 8(4):320-7.
Review The importance of left ventricular hypertrophy in human hypertension. [J Hypertens Suppl. 1998]
Review The importance of left ventricular hypertrophy in human hypertension.
Kahan T. J Hypertens Suppl. 1998 Sep; 16(7):S23-9.
Review Angiotensin-converting enzyme inhibitors and effects on left ventricular hypertrophy. [Blood Press Suppl. 1994]
Review Angiotensin-converting enzyme inhibitors and effects on left ventricular hypertrophy.
Dahlöf B. Blood Press Suppl. 1994; 2:35-40.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound
PubChem chemical compound records that cite the current articles. These references are taken from those provided on submitted PubChem chemical substance records. Multiple substance records may contribute to the PubChem compound record.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Substance
PubChem chemical substance records that cite the current articles. These references are taken from those provided on submitted PubChem chemical substance records.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Free in PMC
Free full text articles in PMC

Recent activity

Clear Turn Off Turn On

Moexipril and left ventricular hypertrophy.
Moexipril and left ventricular hypertrophy.
Vasc Health Risk Manag. 2007 ;3(1):23-30.

PubMed
Framework for securing personal health data in clinical decision support systems...
Framework for securing personal health data in clinical decision support systems.
J Healthc Inf Manag. 2007 Spring ;21(2):34-40.

PubMed
[Evaluation of quality of life in patients with allergic rhinitis].
[Evaluation of quality of life in patients with allergic rhinitis].
J UOEH. 2007 Jun 1 ;29(2):159-67.

PubMed
Lumbar spine loads during the lifting of extremely heavy weights.
Lumbar spine loads during the lifting of extremely heavy weights.
Med Sci Sports Exerc. 1991 Oct ;23(10):1179-86.

PubMed
Evra dose change: an air of secrecy.
Evra dose change: an air of secrecy.
Prescrire Int. 2007 Jun ;16(89):107.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: